This inventor holds 1 USPTO granted patent. Top assignee: Urogen Pharma Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sunil Raju: Innovator in Bladder Cancer Treatment
Introduction
Sunil Raju is a notable inventor based in Princeton, NJ (US), recognized for his contributions to medical science, particularly in the treatment of bladder cancer. His innovative approach focuses on improving patient outcomes through advanced pharmaceutical compositions.
Latest Patents
Sunil Raju holds a patent for a method of treating low-grade intermediate-risk non-muscle-invasive bladder cancer. This patent, titled "Treatment of low-grade intermediate-risk non-muscle-invasive bladder cancer with a thermally gelling pharmaceutical composition containing mitomycin," outlines a method aimed at reducing the risk of tumor recurrence, progression, or death. The method involves administering a thermally gelling pharmaceutical composition once weekly for six weeks to patients diagnosed with this type of cancer. The composition includes a reverse thermal gelation agent, a polymer, and mitomycin, which collectively enhance the probability of disease-free survival at 15 months post-treatment.
Career Highlights
Sunil Raju has made significant strides in his career, particularly through his work at Urogen Pharma Ltd. His dedication to developing effective treatments for bladder cancer has positioned him as a key figure in the pharmaceutical industry. His innovative methods are designed to provide better outcomes for patients facing this challenging diagnosis.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Sunil Raju's work exemplifies the impact of innovation in the medical field, particularly in the treatment of bladder cancer. His patented methods offer hope for improved patient outcomes and highlight the importance of continued research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
